Dr. Robert Schramm, MD
What this data tells you about Dr. Schramm
Dr. Robert Schramm is an allergy & immunology in Boca Raton, FL, with 19 years in practice. Based on federal Medicare data, Dr. Schramm performed 18,065 Medicare services across 1,016 unique beneficiaries.
Between the years covered by Open Payments, Dr. Schramm received a total of $14,974 from 40 pharmaceutical and/or device companies across 409 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy & immunology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schramm is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Omalizumab injection (Xolair) for asthma/allergy | 6,975 | $30 | $149 |
| Allergy skin test | 5,515 | $3 | $10 |
| Test for allergy using allergenic extract injected into skin | 1,294 | $7 | $20 |
| Allergy immunotherapy preparation | 1,147 | $12 | $22 |
| Test for allergy using skin patch | 1,030 | $4 | $20 |
| Office visit, established patient (30-39 min) | 791 | $102 | $170 |
| Allergy injection therapy, multiple injections | 319 | $9 | $18 |
| Test to measure rate of airflow | 228 | $31 | $75 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 202 | $59 | $250 |
| New patient office visit (45-59 min) | 123 | $127 | $300 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 102 | $27 | $200 |
| Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | 76 | $67 | $150 |
| Office visit, established patient (20-29 min) | 49 | $74 | $120 |
| Office visit, established patient, complex (40-54 min) | 42 | $147 | $250 |
| Evaluation of use of breathing device | 30 | $14 | $45 |
| Test to measure the level of nitric oxide gas | 27 | $15 | $75 |
| Flu vaccine, high-dose | 26 | $72 | $140 |
| Flu vaccine administration | 26 | $32 | $60 |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 23 | $0 | $5 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 21 | $32 | $110 |
| New patient office visit, complex (60-74 min) | 19 | $175 | $452 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (85%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
1.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Schramm is a mixed practice specialist, with above-average Medicare volume (top 16% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Schramm experienced with omalizumab injection (xolair) for asthma/allergy?
Does Dr. Schramm receive payments from pharmaceutical companies?
How do Dr. Schramm's costs compare to other allergy & immunologys in Boca Raton?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology